Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by DannyDanboyon May 06, 2020 10:20am
122 Views
Post# 30992585

Thank you Grosdavid

Thank you GrosdavidYou honestly seem to be the only sound mind on this board lol. Everyone else seems to be panicking and jabbering on mindlessly offering no insight whatsoever other than they think they've been swindled. You guys understand trials cost money right? They are trying to see this to the finish line and Canadian government will not provide grant money until their is sufficient DATA. My goodness. The levels of ignorance here are off the charts. IPF and CC in Australia is approval for what was already in the works before COVID hit. And yes we do not need to run another trial for coronavirus. SK, Canada and US (pending submission) should give us sufficient efficacy data. Running a 4th in Australia is not necessary. You guys want quick bucks? Go hit the casino.
<< Previous
Bullboard Posts
Next >>